Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I

Largest profit: MedTrace Pharma A/S (2016) '1,157 DKK

Most equity: MedTrace Pharma A/S (2015) '2,754,628 DKK

Biggest loss: MedTrace Pharma A/S (2015) '2,754,628 DKK

• MedTrace Pharma A/S

  Active

  
  

  Legal owner (2025-05-21 - present) 5% ownership (2025-05-21 – ) 5% voting rights (2025-05-21 – )